Professor and Chief, Gynecologic Oncology University of South Alabama Mitchell Cancer Institute
Obstetrics & Gynecology
Dr. Rodney P. Rocconi, MD
|
|
Give Review
Rodney Rocconi practices Obstetrics & Gynecology. He studied medicine at University of Alabama Medical Center. University of Alabama Medical Center is ranked 37 in research and 17 in primary care medicine He received awards:"Regional Top Doctor" and "Fellow (FACOG)". Rodney Rocconi has written publications. He has 61 publications published with PubMed. The lastest paper is: 'Tissue factor pathway inhibitor (TFPI) antigen plasma level in patients with interstitial lung disease before and after heparin administration.' He accepts all Medicare patients.
Publications
- The role of racial genetic admixture with endometrial Cancer outcomes: An NRG Oncology/Gynecologic Oncology Group study.
- Allyl isothiocyanate induces replication-associated DNA damage response in NSCLC cells and sensitizes to ionizing radiation.
- The trend towards minimally invasive surgery (MIS) for endometrial Cancer: An ASC-NSQIP evaluation of surgical outcomes.
- Gli1 Regulates S-phase Checkpoint in Tumor Cells via Bid and its Inhibition Sensitizes to DNA Topoisomerase 1 Inhibitors.
- Validation of a venous thromboembolism risk assessment model in gynecologic oncology.
- GLI1 upregulates C-JUN through a specific 130-kDa isoform.
- Vaginal Cancer: The Experience From 2 Large Academic Centers During a 15-Year Period.
- Treatment of chemotherapy-induced anemia in ovarian Cancer patients: does the use of erythropoiesis-stimulating agents worsen survival?
- CD44+/CD24- ovarian Cancer cells demonstrate Cancer stem cell properties and correlate to survival.
- Targeted inhibition of telomerase activity combined with chemotherapy demonstrates synergy in eliminating ovarian Cancer spheroid-forming cells.
- Double prophylaxis for deep venous thrombosis in patients with gynecologic oncology who are undergoing laparotomy: does preoperative anticoagulation matter?
- Hedgehog signaling pathway regulates the growth of ovarian Cancer spheroid forming cells.
- The timing of normalization of CA-125 levels during primary chemotherapy is predictive of survival in patients with epithelial ovarian Cancer.
- Patterns of failure for conservatively managed surgical stage I Uterine carcinosarcoma: implications for adjuvant therapy.
- The effect of obesity on survival in patients with ovarian Cancer.
- Expression of c-kit and platelet-derived growth factor receptors in Ovarian granulosa cell tumors.
- Lynch syndrome in women less than 50 years of age with endometrial Cancer.
- Lipoxygenase pathway receptor expression in ovarian Cancer.
- Chemotherapy-related myelosuppression as a marker of survival in epithelial ovarian Cancer patients.
- Serous fallopian tube Carcinoma: a retrospective, multi-institutional case-control comparison to serous adenoCarcinoma of the ovary.
- Complete uterine necrosis following chemoradiation for advanced Cervical cancer: a case report.
- A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent Cervical cancer.
- A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian Cancer ex vivo syste...
- Treatment of ovarian Cancer with a novel dual targeted conditionally replicative adenovirus (CRAd).
- A cost-effectiveness analysis of chemotherapy for patients with recurrent platinum-sensitive epithelial ovarian Cancer.
- Diagnostic loop electrosurgical excisional procedure for discrepancy: do preoperative factors predict presence of significant Cervical intraepithelial neoplasia?
- Combining high selectivity of replication via CXCR4 promoter with fiber chimerism for effective adenoviral oncolysis in breast Cancer.
- Icodextrin enhances survival in an intraperitoneal ovarian Cancer murine model utilizing gene therapy.
- Cervical intraepithelial neoplasia in adolescent women: incidence and treatment outcomes.
- A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial Cancer.
- Recurrence of endometrial adenoCarcinoma in a prior Bartholin's cyst marsupialization incision.
- Gene therapy for ovarian Cancer.
- Unilateral Cervical cancer in a patient with cervix duplex.
- Bowel resection at the time of primary debulking for epithelial ovarian Carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapy.
- The use of bevacizumab to palliate symptomatic ascites in patients with refractory ovarian Carcinoma.
- Role of chemotherapy for patients with recurrent platinum-resistant advanced epithelial ovarian Cancer: A cost-effectiveness analysis.
- Effectiveness of darbepoetin alfa versus epoetin alfa for the treatment of chemotherapy induced anemia in patients with gynecologic malignancies.
- Pegylated liposomal doxorubicin consolidation therapy after platinum/paclitaxel-based chemotherapy for suboptimally debulked, advanced-stage epithelial ovarian Cancer ...
- A comparison of hand-assisted laparoscopy and conventional laparotomy for the surgical evaluation of Pelvic masses.
- Gene transfer to Carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system.
- Outcomes of Stage I/II vulvar Cancer patients after negative superficial inguinal lymphadenectomy.
- Gamma mode of infiltration associated with poor prognosis in malignant teratoma of the ovary: A case report.
- Management strategies for abnormal early pregnancy: a cost-effectiveness analysis.
- Management strategies for stage IB2 Cervical cancer: a cost-effectiveness analysis.
- A cost-effectiveness analysis of screening strategies for Cervical intraepithelial neoplasia.
- Primary lung large cell Carcinoma metastatic to the vulva: a case report and review of the literature.
- ALDH1A1 Maintains Ovarian Cancer Stem Cell-Like Properties by Altered Regulation of Cell Cycle Checkpoint and DNA Repair Network Signaling.
- Postmenopausal uterine inversion associated with endometrial Polyps.
- A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian Cancer.
- The incidence and clinical significance of lymph node micrometastases determined by immunohistochemical staining in stage I - lymph node negative endometrial Cancer.
- Pegfilgrastim for the prevention of febrile neutropenia in patients with epithelial ovarian Carcinoma--a cost-effectiveness analysis.
- Outcomes for patients with fallopian tube Carcinoma managed with adjuvant chemotherapy following primary surgery: a retrospective university experience.
- Employment of liver tissue slice analysis to assay hepatotoxicity linked to replicative and nonreplicative adenoviral agents.
- Outcomes of gynecologic oncology patients admitted to the intensive care unit following surgery: A university teaching hospital experience.
- Tissue factor pathway inhibitor (TFPI) antigen plasma level in patients with interstitial lung disease before and after heparin administration.
- Signs of aging or the vague symptoms of ovarian Cancer?
- Overcoming technical challenges with robotic surgery in gynecologic oncology.
- Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast Carcinoma.
- Targeted gene therapy for ovarian Cancer.
- Complications of indwelling venous access devices in patients with gynecologic malignancies.
Schools
Univ Of Al Sch Of Med
University Of Al Hospital
Procedures Preformed
- Colposcopy
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- Destruction or Excision of Vaginal Lesions
- Dilation and Curettage
- View All
Conditions Treated
- Carcinoma in Situ
- Cervical Cancer
- Cervical Polyps
- Endometriosis
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Dental Blue 100/200/300
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- Regional Top Doctor
- Fellow (FACOG)
Education
-
University of Alabama Medical Center -
University of Alabama School of Medicine
Drug Facts
| NPI NUMBER | 1730131210 | |
| NPPES Provider LastName | ROCCONI | |
| NPPES Provider FirstName | RODNEY | |
| NPPES Provider ZIPCode | 366400430 | |
| NPPES Provider State | AL | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 225.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 78.0 | |
| Percent Opioid Claims | 34.67 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1730131210 |
| Last Name Of The Provider | ROCCONI |
| First Name Of The Provider | RODNEY |
| View All |
Similar Doctors
|
|
Dr. Julie G. Grinstead, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. William J. Roy Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Oscar D. Almeida Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael A. Finan, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. John M. Ives Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paula J. Sullivan, DO
This Doctor is OpenDoctor Recommended.
|